The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Gabapentin (neurontin) and S‐(+)‐3‐isobutylgaba represent a novel class of selective antihyperalgesic agents
Open accessAbstract
Gabapentin (neurontin) is a novel antiepileptic agent that binds to the α 2 δ subunit of voltage‐dependent calcium channels. The only other compound known to possess affinity for this recognition site is the (S)‐(+)‐enantiomer of 3‐isobutylgaba. However, the corresponding (R)‐(−)‐enantiomer is 10 fold weaker. The present study evaluates the activity of gabapentin and the two enantiomers of 3‐isobutylgaba in formalin and carrageenan‐induced inflammatory pain models. In the rat formalin test, S‐(+)‐3‐isobutylgaba (1–100 mg kg−1) and gabapentin (10–300 mg kg−1) dose‐dependently inhibited the late phase of the nociceptive response with respective minimum effective doses (MED) of 10 and 30 mg kg−1, s.c. This antihyperalgesic action of gabapentin was insensitive to naloxone (0.1–10.0 mg kg−1, s.c.). In contrast, the R‐(−)‐enantiomer of 3‐isobutylgaba (1–100 mg kg−1) produced a modest inhibition of the late phase at the highest dose of 100 mg kg−1. However, none of the compounds showed any effect during the early phase of the response. The s.c. administration of either S‐(+)‐3‐isobutylgaba (1–30 mg kg−1) or gabapentin (10–100 mg kg−1), after the development of peak carrageenan‐induced thermal hyperalgesia, dose‐dependently antagonized the maintenance of this response with MED of 3 and 30 mg kg−1, respectively. Similar administration of the two compounds also blocked maintenance of carrageenan‐induced mechanical hyperalgesia with MED of 3 and 10 mg kg−1, respectively. In contrast, R‐(−)‐3‐isobutylgaba failed to show any effect in the two hyperalgesia models. The intrathecal administration of gabapentin dose‐dependently (1–100 μg/animal) blocked carrageenan‐induced mechanical hyperalgesia. In contrast, administration of similar doses of gabapentin into the inflamed paw was ineffective at blocking this response. Unlike morphine, the repeated administration of gabapentin (100 mg kg−1 at start and culminating to 400 mg kg−1) over 6 days did not lead to the induction of tolerance to its antihyperalgesic action in the formalin test. Furthermore, the morphine tolerance did not cross generalize to gabapentin. The s.c. administration of gabapentin (10–300 mg kg−1), R‐(−) (3–100 mg kg−1) or S‐(+)‐3‐isobutylgaba (3–100 mg kg−1) failed to inhibit gastrointestinal motility, as measured by the charcoal meal test in the rat. Moreover, the three compounds (1–100 mg kg−1, s.c.) did not generalize to the morphine discriminative stimulus. Gabapentin (30–300 mg kg−1) and S‐(+)‐isobutylgaba (1–100 mg kg−1) showed sedative/ataxic properties only at the highest dose tested in the rota‐rod apparatus. Gabapentin (30–300 mg kg−1, s.c.) failed to show an antinociceptive action in transient pain models. It is concluded that gabapentin represents a novel class of antihyperalgesic agents. British Journal of Pharmacology (1997) 121, 1513–1522; doi:10.1038/sj.bjp.0701320
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia
Hargreaves, K., Dubner, R., Brown, F., Flores, C., & Joris, J. (1988) · Pain · doi:10.1016/0304-3959(88)90026-7 · Cited by 5,135
Dubuisson, D., & Dennis, S. G. (1977) · Pain · doi:10.1016/0304-3959(77)90130-0 · Cited by 2,524
Evidence for a central component of post-injury pain hypersensitivity
Woolf, C. J. (1983) · Nature · doi:10.1038/306686a0 · Cited by 2,157
A method for measurement of analgesic activity on inflamed tissue.
Randall, L. O., & Selitto, J. J. (1957) · PubMed · Cited by 1,577
The Novel Anticonvulsant Drug, Gabapentin (Neurontin), Binds to the α2δ Subunit of a Calcium Channel
Gee, N. S., Brown, J. P., Dissanayake, V. U. K., Offord, J., Thurlow, R., & Woodruff, G. N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.10.5768 · Cited by 1,181
CALCIUM CHANNEL DIVERSITY AND NEUROTRANSMITTER RELEASE: The ω-Conotoxins and ω-Agatoxins
Olivera, B. M., Miljanich, G. P., Ramachandran, J., & Adams, M. E. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.004135 · Cited by 734
Auxiliary subunits of voltage-gated ion channels
Isom, L. (1994) · Neuron · doi:10.1016/0896-6273(94)90436-7 · Cited by 564
Woolf, C., & Wall, P. (1986) · The Journal of Neuroscience · doi:10.1523/jneurosci.06-05-01433.1986 · Cited by 559
Williams, M. E., Feldman, D. H., McCue, A. F., Brenner, R., Velicelebi, G., Ellis, S. B., & Harpold, M. M. (1992) · Neuron · doi:10.1016/0896-6273(92)90109-q · Cited by 499
Molecular Basis for CA2+ Channel Diversity
Hofmann, F., Biel, M., & Flockerzi, V (1994) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.17.030194.002151 · Cited by 473
Tricklebank, M. D., Singh, L., Oles, R. J., Preston, C., & Iversen, S. D. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90754-1 · Cited by 433
Self-citationUchitel, O. D., Protti, D. A., Sanchez, V, Cherksey, B. D., Sugimori, M., & Llinás, R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3330 · Cited by 404
Nitric oxide mediates the thermal hyperalgesia produced in a model of neuropathic pain in the rat
Meller, S. T., Pechman, P. S., Gebhart, G. F., & Maves, T. J. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90377-e · Cited by 377
Standardization of the rat paw formalin test for the evaluation of analgesics
Wheeler-Aceto, H., & Cowan, A. (1991) · Psychopharmacology · doi:10.1007/bf02244551 · Cited by 367
The rat paw formalin test: comparison of noxious agents
Wheeler-Aceto, H., Porreca, F., & Cowan, A. (1990) · Pain · doi:10.1016/0304-3959(90)90073-m · Cited by 350
Gabapentin: A Review of its Pharmacological Properties and Clinical Potential in Epilepsy
Goa, K. L., & Sorkin, E. M. (1993) · Drugs · doi:10.2165/00003495-199346030-00007 · Cited by 323
Calcium Channels Coupled to Glutamate Release Identified by ω-Aga-IVA
Turner, T. J., Adams, M. E., & Dunlap, K. (1992) · Science · doi:10.1126/science.1357749 · Cited by 297
Gurnett, C. A., De Waard, M., & Campbell, K. P. (1996) · Neuron · doi:10.1016/s0896-6273(00)80061-6 · Cited by 290
Malmberg, A., & Yaksh, T. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-08-04882.1994 · Cited by 288
Multiple Ca2+ channel types coexist to regulate synaptosomal neurotransmitter release.
Turner, T. J., Adams, M. E., & Dunlap, K. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9518 · Cited by 268
Dickenson, A. H., & Sullivan, A. F. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90242-4 · Cited by 264
Meller, S. T., Cummings, C. P., Traub, R. J., & Gebhart, G. F. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90250-x · Cited by 229
Characterisation of [3H]gabapentin binding to a novel site in rat brain: homogenate binding studies
Suman-Chauhan, N., Webdale, L., Hill, D. R., & Woodruff, G. N. (1993) · European Journal of Pharmacology: Molecular Pharmacology · doi:10.1016/0922-4106(93)90155-3 · Cited by 225
Singh, L., Field, M. J., Ferris, P., Hunter, J. C., Oles, R. J., Williams, R. G., & Woodruff, G. N. (1996) · Psychopharmacology · doi:10.1007/bf02805968 · Cited by 221
Self-citationFormalin induces biphasic activity in C-fibers in the rat
McCall, W. D., Tanner, K. D., & Levine, J. D. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12552-0 · Cited by 185
Gabapentin in the management of reflex sympathetic dystrophy
Mellick, G. A., Mellicy, L. B., & Mellick, L. B. (1995) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(95)00001-f · Cited by 181
Kayser, V., & Guilbaud, G. (1987) · Pain · doi:10.1016/0304-3959(87)91064-5 · Cited by 179
Díaz, Á., & Dickenson, A. H. (1997) · Pain · doi:10.1016/s0304-3959(96)03271-x · Cited by 154
Taylor, C. P., Vartanian, M. G., Yuen, P., et al. (1993) · Epilepsy Research · doi:10.1016/0920-1211(93)90070-n · Cited by 150
Stanfa, L. C., Sullivan, A. F., & Dickenson, A. H. (1992) · Pain · doi:10.1016/0304-3959(92)90040-i · Cited by 144
McLean, M. J. (1995) · Epilepsia · doi:10.1111/j.1528-1157.1995.tb06001.x · Cited by 137
Woolf, C. J. (1994) · Drugs · doi:10.2165/00003495-199400475-00003 · Cited by 132
REACTION THRESHOLDS TO PRESSURE IN EDEMATOUS HINDPAWS OF RATS AND RESPONSES TO ANALGESIC DRUGS
Winter, C. A., & Flataker, L. (1965) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)27163-4 · Cited by 129
Sherman, R. A., Griffin, V. D., Evans, C. B., & Grana, A. S. (1992) · International Journal of Psychophysiology · doi:10.1016/0167-8760(92)90022-4 · Cited by 93
Gaur, S., Newcomb, R., Rivnay, B., BELL, J. R., Yamashiro, D., Ramachandran, J., & Miljanich, G. P. (1994) · Neuropharmacology · doi:10.1016/s0028-3908(05)80012-7 · Cited by 83
Spinal Mediators of Hyperalgesia
Meller, S. T., & Gebhart, G. F. (1994) · Drugs · doi:10.2165/00003495-199400475-00004 · Cited by 70
Winter, C. A., & Flataker, L. (1965) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)27061-6 · Cited by 52
Singh, L., Oles, R. J., Field, M. J., Atwal, P., Woodruff, G. N., & Hunter, J. C. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15539.x · Cited by 31
Self-citation
Cited by
The induction of pain: an integrative review
Millan, M. J. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00048-3 · Cited by 1,774
TRPA1 mediates formalin-induced pain
McNamara, C. R., Mandel-Brehm, J., Bautista, D. M., Siemens, J., Deranian, K. L., Zhao, M., Hayward, N. J., Chong, J. A., Julius, D., Moran, M. M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705924104 · Cited by 1,263
Morphine, Gabapentin, or Their Combination for Neuropathic Pain
Gilron, I., Bailey, J. M., Tu, D., Holden, R. R., Weaver, D. F., & Houlden, R. L. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042580 · Cited by 1,091
A summary of mechanistic hypotheses of gabapentin pharmacology
Taylor, C. P., Gee, N. S., Su, T.-Z., Kocsis, J. D., Welty, D. F., Brown, J. P., Dooley, D. J., Boden, P., & Singh, L. (1998) · Epilepsy Research · doi:10.1016/s0920-1211(97)00084-3 · Cited by 774
Self-citationPregabalin for the treatment of postherpetic neuralgia: A randomized, placebo-controlled trial
Dworkin, R. H., Corbin, A. E., Young, J. P., Sharma, U., LaMoreaux, L., Bockbrader, H., Garofalo, E. A., & Poole, R. M. (2003) · Neurology · doi:10.1212/01.wnl.0000055433.55136.55 · Cited by 768
Metadata
- Authors
- Field, M. J., Oles, R. J., Lewis, A. S., McCleary, S., Hughes, J., & Singh, L.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 1997-08
- Volume
- 121
- Issue
- 8
- Pages
- 1513-1522
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2027053525
- Cited by
- 326
- References
- 38
- FWCI
- 6.51
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.